Who is sponsoring NCT00804609?

NCT00804609 is sponsored by Stanford University.

What condition does NCT00804609 study?

NCT00804609 studies Epidural Analgesia, Obstetric.

What drugs are being tested in NCT00804609?

Interventions: DepoDur following epidural lidocaine, DepoDur following spinal anesthetic.

What is the status of NCT00804609?

NCT00804609 is currently COMPLETED.

Last reviewed 2017-09-11 · How we verify

A Study to Evaluate the Effects of Epidural Lidocaine Administration on the Pharmacokinetic and Pharmacodynamic Profiles of DepoDur® (Morphine Sulfate Extended-release Injection) in Patients Undergoing Cesarean Delivery

NCT00804609 NA COMPLETED Results posted

To evaluate the levels of morphine in a patient's blood when morphine is given into the epidural space in the form of DepoDur® either alone or following a dose of lidocaine also given in the epidural space.

Details

Lead sponsor	Stanford University
Phase	NA
Status	COMPLETED
Enrolment	30
Start date	2008-09
Completion	2010-12

Conditions

Epidural Analgesia, Obstetric

Interventions

DepoDur following epidural lidocaine
DepoDur following spinal anesthetic

Primary outcomes

Maximum Plasma Concentration (Cmax) of Extended Release Epidural Morphine (EREM) — a plasma sample at 0, 5, 10, 15, and 30 minutes, and 1, 4, 8, 12, 24, 36, 48, and 72 hours post-dose
The primary end point was to evaluate the pharmacokinetic profiles of EREM after either no epidural lidocaine or after an epidural lidocaine top-up for cesarean delivery.

Countries

United States